Navigation Links
Co-Inventor of Amgen's Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals' First-in-Class Oxygen Enhancing Therapeutics
Date:12/21/2007

CHARLOTTESVILLE, Va., Dec. 21 /PRNewswire/ -- Diffusion Pharmaceuticals LLC, a clinical stage drug-development company commercializing first-in-class drugs utilizing a novel mechanism of action that enhances oxygen diffusion, today announced that one of its key advisors, Mr. Thomas Byrne, was recently recognized as a co-inventor of the underlying technology of Amgen's blockbuster drug Aranesp(R) (darbepoietin alpha), a erythropoiesis stimulating agent (US Patent No. 7,217,689).

Mr. Byrne, who is an Officer of Diffusion Pharmaceuticals and a member of its Board of Directors, has directed the worldwide intellectual property strategy of the Company since its inception in February 2001. His experience includes in-house counsel positions within both Genentech and Amgen.

"We are exceptionally fortunate to have such an experienced pharmaceutical development executive with scientific acumen and expertise in related intellectual property law leading our worldwide patent strategy and helping to guide the company," says David G. Kalergis, Diffusion Pharmaceuticals' Chief Executive Officer.

About Diffusion Pharmaceuticals LLC

Diffusion Pharmaceuticals LLC is a clinical-stage drug-development company commercializing a family of first-in-class drug candidates to treat serious or life-threatening medical conditions. These proprietary small molecules use a novel method of action to enhance oxygen diffusion to oxygen deprived (hypoxic) tissue. Potential clinical applications include critical care uses such as trauma, hemorrhage, stroke and heart attack, and cancer as well as chronic conditions such as cardiovascular disease, respiratory disorders, anemia and peripheral vascular disease. Enhanced diffusion of oxygen into hypoxic tissue has an important application in oncology by improving the efficacy of radiation therapy in cancerous tumors. The Company's first Phase I clinical trial for its lead molecule, trans sodium crocetinate (TSC), shows the
'/>"/>

SOURCE Diffusion Pharmaceuticals LLC
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Novel Technology Breaks Through Cancer Pain
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. China Technology Announces New Chief Financial Officer
11. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...hould Die of Diabetes, BRUSSELS, October 13 /PRNe...IDF) announced today that it is bringing together ...are for the thousands of children,with diabetes in...e meeting, Access to Essential Diabetes Medicines ... on Saturday, October 25 in London, United,Kingdom...
(Date:10/13/2008)...wswire-FirstCall/ -- Thursday and Friday of,last w...ic,s (NYSE: BSX ),stock. As anticipated in the Co...rtion of this trading was due to involuntary sales...,s co-founders Pete Nicholas and,John Abele. As of...31,million shares in aggregate had been sold last ...
(Date:10/13/2008)... /- WebLOQ, Inc., the emerging,leader...nt eBusiness and,data-in-motion communications, to...ployed the WebLOQ ePrivacy solution in their state...h their healthcare partner, the,Monterey Peninsula...plemented WebLOQ,s hosted, on demand ePrivacy tech...
(Date:10/13/2008)...ctober 13 /-,Following fulf...as now,completed the acquisition* of all outstandi... in prescription optical equipment., Satisloh des...surfacing,machines, as well as consumables, for pr...n in revenue in 2007 and employs more than 400 peo...
Breaking Biology Technology:International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders 2Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders 3Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange 2Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange 3
...rs Note: Wisconsins Department of Workforce Deve...gthening the states workforce. The department has ...bs, increase wages, address workforce shortages an...o Wisconsin workers. Secretary Roberta Gassman in ... talks about how DWD is investing in people and ho...
...EE-- ARI , a provider of business solutions that c...and distribution networks, announced today that Ha...t to license ARI,s EMPARTweb e-Catalog solution fo...okup and ordering service within their dealer webs...web, provide ongoing updates for selected manufact...
...eld, Wis.-- Fiserv Credit Processing Services se...t solutions to help ensure response time of its cr... Fiserv Credit Processing Services provides outso...s a unit of Fiserv, Inc. , ,Fiserv Credit Processi...enhances their ability to manage credit decisions,...
...s suggest 1500 Megawatts of Electricity Could Be S...e Wisconsin, especially after the California Energ... paradigm shift. There was a time when the major p...d with the utilities, the federal government and i...the environmental component of each decision made ...
Other Biology Technology:WTN Interview: Roberta Gassman 2WTN Interview: Roberta Gassman 3Wisconsins Businesses Can Become Environmental Leaders 2Wisconsins Businesses Can Become Environmental Leaders 3
(Date:10/12/2008)...built-in weapon against HIV, but until recently no... published online by the journal Nature reveals ...wn as APOBEC-3G and suggests new directions for d... human cell. It is capable of stopping HIV at the ...nscribes its RNA into viral DNA. , The study,s a...
(Date:10/10/2008)...formation technology have shaped not only how we f... medicines. A project just funded by the National ...drug design to the next level. , The University ...ance the molecular data needed to develop computer...rug candidates. The data will be housed in a Web-b...
(Date:10/10/2008)...om the Peninsula Medical School in Plymouth, UK, h...r of moderate exercise a day recommended to childr... the rising problem of childhood obesity. , Thei...ssue of the journal "Archives of Diseases in Child...dy, which has followed the development of over 200...
(Date:10/10/2008)...is available in German . , DNA, the molecule ... all forms of life, is highly resistant against al...he mechanism for its photostability presents some ... between the four chemical bases that make up the ...succeeded in showing that DNA strands differ in th...
Breaking Biology News(10 mins):Body's anti-HIV drug explained 2New data resource to advance computer-aided drug design 2Recommendations for children's exercise lacking say experts 2Can genetic information be controlled by light? 2Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 1Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 2Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 3Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference 26734 1Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference 26734 2Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference 26734 3LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 26729 1LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 26729 2LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 26729 3New Report on 633 Biotechnology Medicines Under Development Released in Michigan 7901 1New Report on 633 Biotechnology Medicines Under Development Released in Michigan 7901 2New Report on 633 Biotechnology Medicines Under Development Released in Michigan 7901 3
... experiments of their kind, researchers at Rice Un...n Cancer Center have determined that carbon nanotu...arch lab animals cause no immediate adverse health...re they are removed by the liver. , The findings a...ly unmodified carbon nanotubes, a revolutionary na...
...mal model, brain researchers in Göttingen have exa...n humans. These are mutations in the genes which c... neuroligin family. The study published in the sci...that neuroligins ensure that signal transmission b...tically altered mice without neuroligins, the cont...
... for targeting malignant brain tumors through indu...een developed by a team of researchers headed by a...emistry. , Alexander Levitzki, who is the Wolfs...associate, Dr. Alexei Shir, and his colleagues fro...many, have pioneered a technique in which a molecu...
...us previously used as a marker in tracing human mi...s at Penn State. Results of this study also sugges...r rates of evolution than previously thought. , "T...e in Africa," said Laura Shackelton, a postdoctora... Disease Dynamics. "But, in the case of this virus...
Other Biology News:Pure carbon nanotubes pass first in vivo test 2When nerve cells can't make contact 2When nerve cells can't make contact 3When nerve cells can't make contact 4 Killing brain tumors from within: A 'Trojan horse' approach 2Viral marker of human migration suspect 2
...ly Gradient thermal cycler which enables you to op... ,Wide linear gradient - The most linear gradient...C. Protocols can be optimised in a single experime...orates a large, 115 x 90mm, touch-sensitive screen...
... with a comprehensive array of accessories. JULAB...s, splash-water protected keypad offer a high oper...cating up to 6 temperature values is visible from ... with PID temperature control eliminates temperatu...
...abilizer is an aqueous solution that contains a pu...ing chemicals in a MOPS buffer (3-(N-Morpholino) p...ontains a combination of 0.02% methylisothiazolone...Rohm and Haas Company) as a preservative. StabilZ...
Request Info
Biology Products: